Outcomes after combined liver-kidney transplant vs. kidney transplant followed by liver transplant

被引:2
|
作者
Chan, Edie Y. [1 ]
Bhattacharya, Renuka [2 ]
Eswaran, Sheila [3 ]
Hertl, Martin [1 ]
Shah, Nikunj [3 ]
Fayek, Sameh [1 ]
Cohen, Eric B. [3 ]
Hollinger, Edward F. [1 ]
Olaitan, Oyedolamu [1 ]
Jensik, Stephen C. [1 ]
Perkins, James D. [4 ]
机构
[1] Rush Univ, Med Ctr, Dept Gen Surg, Chicago, IL 60612 USA
[2] Univ Washington, Med Ctr, Dept Med, Seattle, WA 98195 USA
[3] Rush Univ, Med Ctr, Dept Med, Chicago, IL 60612 USA
[4] Univ Washington, Med Ctr, Dept Surg, Seattle, WA 98195 USA
关键词
cirrhosis; combined liver-kidney transplant; kidney transplant; liver transplant; outcomes; C VIRUS-INFECTION; CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; CIRRHOSIS; SURVIVAL; FIBROSIS; MORTALITY; PRESSURE; PATIENT; IMPACT;
D O I
10.1111/ctr.12484
中图分类号
R61 [外科手术学];
学科分类号
摘要
IntroductionThe decision for isolated kidney transplant (KT) vs. combined liver-kidney transplant (CLKT) in patients with end-stage renal disease (ESRD) with compensated cirrhosis remains controversial. We sought to determine outcomes of patients requiring listing for a liver transplant (LT) following either a cadaveric or living donor KT and compare these outcomes to similar patients receiving a CLKT. MethodsOur dataset included the United Network for Organ Sharing (UNOS)/Standard Transplant and Analysis and Research (STAR) kidney files from 1987 to 2012 after being joined with the liver files from 2002 to 2012. Outcomes of patients who received a CLKT with an international normalized ratio (INR) 1 and total bilirubin 1 were compared to patients who received a primary KT and subsequently required listing for LT between zero and fiveyr or after fiveyr. ResultsFor the three groups, 244 patients had a CLKT, 216 were wait-listed for LT between zero and fiveyr after KT (0-5 WL), and 320 were wait-listed fiveyr after KT (+5 WL). From the time of KT, the 0-5 WL group had significantly worse survival than the CLKT group and the +5 WL group. The +5 WL had the best survival of all groups. For the 0-5 WL group, 45% underwent LT and 40% died while waiting compared to the +5 WL group with 53% having LT and 26% died while waiting. At the time of LT, the 0-5 WL group had a higher model for end-stage liver disease (MELD) score, higher incidence of being in the ICU at the time of transplant, and higher incidence of requiring life support. From the time of LT, the CLKT trended toward better survival (p=0.0549) than both the 0-5 WL and +5 WL groups, which had equivalent survival. ConclusionThe 0-5 WL group is a higher risk group with poorer survival due to a higher incidence of dying on the waitlist. Better identification of patients with a high risk for hepatic decompensation following KT and agreement for regional exception for LT in the event of decompensation may improve utilization of organs and better survival for those patients.
引用
收藏
页码:60 / 66
页数:7
相关论文
共 50 条
  • [41] Preoperative Echocardiographic Differences and Transplant Outcomes Among Patients Receiving Simultaneous Liver-Kidney Versus Liver Transplant Alone
    Mazumder, Nik R.
    Russell, Stuart D.
    Pustavoitau, Aliaksei
    Chacko, Matthews
    Rizkalla, Nicole
    Saberi, Behnam
    Philosophe, Benjamin
    Cameron, Andrew M.
    Gurakar, Ahmet
    Naqvi, Fizza F.
    [J]. EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2018, 16 : 9 - 13
  • [42] Long-Term Outcomes of Simultaneous Liver-Kidney Transplant Patients with Hepatitis B Compared to with Liver Transplant Alone
    Li, Hao
    Fan, Ming-Qi
    Men, Tong-Yi
    Wang, Yun-Peng
    Xing, Tong-Hai
    Fan, Jun-Wei
    Peng, Zhi-Hai
    Zhong, Lin
    [J]. MEDICAL SCIENCE MONITOR, 2016, 22 : 332 - 340
  • [43] Outcomes of Combined vs. Sequential Heart-Kidney Transplant
    Gallo, M.
    Trivedi, J. R.
    Whited, W. M.
    Slaughter, M. S.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S386 - S386
  • [44] Rejection and Survival Outcomes in Simultaneous Liver Kidney Transplant versus Kidney After Liver
    Ghali, P.
    Attieh, R.
    Croome, K.
    White, L.
    Hodge, D.
    Wadei, H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S421 - S421
  • [45] Evaluation of native kidney (NK) recovery after simultaneous liver-kidney transplant (SLK).
    Francis, Jean
    Palmer, Matthew
    Curry, Michael
    Patel, Parul
    Pavlakis, Martha
    Johnson, Scott
    Karp, Seth
    Khwaja, Khalid
    Donohoe, Kevin
    Hanto, Doug
    Mandelbrot, Didier
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 337 - 337
  • [46] Rhodotorula glutinis fungemia in a liver-kidney transplant patient
    Riedel, D. J.
    Johnson, J. K.
    Forrest, G. N.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2008, 10 (03) : 197 - 200
  • [47] Early kidney after liver transplant has equivalent survival compared with simultaneous liver-kidney transplant : The promise of the "safety net" and importance of KDPI
    Jay, Colleen
    Rogers, Jeffrey
    Washburn, W. Kenneth
    Heimbach, Julie
    Stratta, Robert
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 17 - 17
  • [48] Hyperammonemia syndrome due to Ureaplasma infection after liver-kidney transplant
    Cannon, Chase A.
    Corcorran, Maria A.
    Shaw, Kathryn W.
    Montenovo, Martin
    Sibulesky, Lena
    Reyes, Jorge D.
    Rayhill, Stephen C.
    Larson, Anne M.
    Kritek, Patricia A.
    Giovanni, Shewit
    de Castro, Iris
    Arora, Nayan
    Rakita, Robert M.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2020, 22 (03)
  • [49] Optimizing the Selection of Patients for Simultaneous Liver-Kidney Transplant
    Bari, Khurram
    Sharma, Pratima
    [J]. CLINICS IN LIVER DISEASE, 2021, 25 (01) : 89 - 102
  • [50] Basiliximab Induction in Simultaneous Liver-Kidney Transplant.
    Song, C.
    Luo, X.
    Pote, L.
    Strout, S.
    Segev, D.
    Desai, N.
    Gurakar, A.
    Navqi, F.
    Wang, J. Garonzik
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 680 - 680